CY1120970T1 - PHARMACEUTICAL DOSAGE FORM INCLUDING 6'-Fluoro- (N-METHYL-Ή N, N-DIMETHYL -) - 4-PHENYL-4 ', 9'-DIHYDRO-3-KY-SPO , 4, B] INDOL] -4-AMINH FOR THE TREATMENT OF ALGESTIC PAIN - Google Patents

PHARMACEUTICAL DOSAGE FORM INCLUDING 6'-Fluoro- (N-METHYL-Ή N, N-DIMETHYL -) - 4-PHENYL-4 ', 9'-DIHYDRO-3-KY-SPO , 4, B] INDOL] -4-AMINH FOR THE TREATMENT OF ALGESTIC PAIN

Info

Publication number
CY1120970T1
CY1120970T1 CY181101280T CY181101280T CY1120970T1 CY 1120970 T1 CY1120970 T1 CY 1120970T1 CY 181101280 T CY181101280 T CY 181101280T CY 181101280 T CY181101280 T CY 181101280T CY 1120970 T1 CY1120970 T1 CY 1120970T1
Authority
CY
Cyprus
Prior art keywords
indol
dihydro
fluoro
dimethyl
phenyl
Prior art date
Application number
CY181101280T
Other languages
Greek (el)
Inventor
Nadja Grüning
Marc Schiller
Ingo Friedrich
Chris Kirby
Ashish Hemani
John Bothmer
Andreas Scholz
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP11745929.7A external-priority patent/EP2600850B1/en
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of CY1120970T1 publication Critical patent/CY1120970T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η εφεύρεση αφορά μία φαρμακευτική μορφή δοσολογίας για χορήγηση μία φορά την ημέρα που περιέχει 6'-φθορο-(Ν-μεθυλ- ή Ν,Ν-διμεθυλ-)-4-φαινυλ-4',9'-διυδρο-3'1-1-σπειρο[κυκλοεξανο-1,1'-πυρανο[3,4b]ινδολ]-4-αμίνη ή ένα φυσιολογικά αποδεκτό άλας αυτής για χρήση στην αγωγή του αλγαισθητικού πόνου, κατά προτίμηση οξέος ή χρόνιου αλγαισθητικού πόνου.The invention relates to a pharmaceutical dosage form for once daily administration containing 6'-fluoro- (N-methyl- or N, N-dimethyl-) -4-phenyl-4 ', 9'-dihydro-3'1- 1-helix [cyclohexane-1,1'-pyrano [3,4b] indol] -4-amine or a physiologically acceptable salt thereof for use in the treatment of analgesic pain, preferably acute or chronic analgesic pain.

CY181101280T 2010-08-04 2018-12-03 PHARMACEUTICAL DOSAGE FORM INCLUDING 6'-Fluoro- (N-METHYL-Ή N, N-DIMETHYL -) - 4-PHENYL-4 ', 9'-DIHYDRO-3-KY-SPO , 4, B] INDOL] -4-AMINH FOR THE TREATMENT OF ALGESTIC PAIN CY1120970T1 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US37063410P 2010-08-04 2010-08-04
US37064310P 2010-08-04 2010-08-04
US37064810P 2010-08-04 2010-08-04
EP10008116 2010-08-04
EP10008117 2010-08-04
EP10008115 2010-08-04
EP11745929.7A EP2600850B1 (en) 2010-08-04 2011-08-04 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for the treatment of nociceptive pain
PCT/EP2011/003907 WO2012016697A2 (en) 2010-08-04 2011-08-04 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for the treatment of nociceptive pain

Publications (1)

Publication Number Publication Date
CY1120970T1 true CY1120970T1 (en) 2019-12-11

Family

ID=65444400

Family Applications (2)

Application Number Title Priority Date Filing Date
CY181100617T CY1120616T1 (en) 2010-08-04 2018-06-13 PHARMACEUTICAL FORM DOSAGE WHICH INCLUDES 6'-Fluoro- (N-METHYL- Ή N, N-DIMETHYL-) - 4-PHENYL-4 ', 9'-DIHYDRO-3'H-SP1 PYRANO [3,4, Β] INDOL] -4-AMINE FOR THE TREATMENT OF NEUROPATHY PAIN
CY181101280T CY1120970T1 (en) 2010-08-04 2018-12-03 PHARMACEUTICAL DOSAGE FORM INCLUDING 6'-Fluoro- (N-METHYL-Ή N, N-DIMETHYL -) - 4-PHENYL-4 ', 9'-DIHYDRO-3-KY-SPO , 4, B] INDOL] -4-AMINH FOR THE TREATMENT OF ALGESTIC PAIN

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY181100617T CY1120616T1 (en) 2010-08-04 2018-06-13 PHARMACEUTICAL FORM DOSAGE WHICH INCLUDES 6'-Fluoro- (N-METHYL- Ή N, N-DIMETHYL-) - 4-PHENYL-4 ', 9'-DIHYDRO-3'H-SP1 PYRANO [3,4, Β] INDOL] -4-AMINE FOR THE TREATMENT OF NEUROPATHY PAIN

Country Status (4)

Country Link
CY (2) CY1120616T1 (en)
ES (1) ES2702528T3 (en)
HU (1) HUE041960T2 (en)
PT (1) PT2600850T (en)

Also Published As

Publication number Publication date
HUE041960T2 (en) 2019-06-28
CY1120616T1 (en) 2019-12-11
ES2702528T3 (en) 2019-03-01
PT2600850T (en) 2018-12-04

Similar Documents

Publication Publication Date Title
MX354686B (en) Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1 '-pyrano[3,4,b]indol]-4-amine for the treatment of neuropathic pain.
CY1116727T1 (en) Multiple Sclerosis Treatment With LAQUINIMOD
ECSP13012421A (en) PHARMACEUTICAL DOSAGE FORM INCLUDING 6'-FLUORO- (N-METHYL-ON, N-DIMETILE) -4-PHENYL-4 ', 9'-DIHIDRO-3'H-ESPIRO [CICLOHEXAN-1,1'-PIRANO [ 3,4, b] INDOL] -4-AMINA
NZ605841A (en) Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
MX2009002196A (en) Buprenophine-wafer for drug substitution therapy.
NZ700924A (en) Dosage regimen for a pi-3 kinase inhibitor
CY1119887T1 (en) PHARMACEUTICAL FORM OF DOSAGE CONTAINING 6'-FLYOR- (N-Methyl-N, N-Dimethyl -) - 4-FENYLO-4 ', 9'-DYYRO-3'-DYYL-3'H [3,4, b] INDOL] -4-AMINE
DK2244703T3 (en) Drug and the preparation and use thereof in the treatment of painful neuropathies
AR072951A1 (en) USE OF DRONEDARONE OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THIS, FOR THE PREPARATION OF A MEDICINAL PRODUCT TO REGULATE THE LEVEL OF POTASSIUM IN THE BLOOD
EA201390950A1 (en) HOMOGENEOUS PHARMACEUTICAL ORAL DOSAGE FORMS CONTAINING LERKANIDIPIN AND ENALAPRIL OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS TOGETHER WITH ORGANIC ACID
CY1120970T1 (en) PHARMACEUTICAL DOSAGE FORM INCLUDING 6'-Fluoro- (N-METHYL-Ή N, N-DIMETHYL -) - 4-PHENYL-4 ', 9'-DIHYDRO-3-KY-SPO , 4, B] INDOL] -4-AMINH FOR THE TREATMENT OF ALGESTIC PAIN
EA201590732A1 (en) DISPENSABLE TABLET
EA201291420A1 (en) ORAL MEDICAL FORMS CONTAINING LERCANIDIPIN AND ENALAPRIL AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS
CY1118799T1 (en) (1R, 4R) -6'-Fluoro- (N-Methyl-N, N-Dimethyl -) - 4-phenyl-4 ', 9'-dihydro-3'H-spiro- [CYCLOEXANO-1,1' PYRANO [3,4, B] INDOL] -4-AMINE FOR TREATMENT OF FIOMOYLGY AND YOUNG COUPE SYNDROME
EA201491046A1 (en) TRANSMUKOSAL'S DEVICES FOR DELIVERY OF MEDICINES FOR USE IN THE RELIEF OF CHRONIC PAIN
CY1116996T1 (en) PHARMACEUTICAL DOSAGE CONTAINING 6'-FLUOR- (N-METHYL-N, N-DIMETHYL -) - 4-FINYL-4 ', 9', - DYYDRO-3'H-SPYRO [3,4-B] INDOL] -4-AMINE PYRANO
CY1117605T1 (en) Crohn's disease treatment with LAQUINIMOD
CY1117385T1 (en) 6'-Fluoro- (N-Methyl-,N, N-Dimethyl -) - 4-phenyl-4΄, 9'-dihydro-3'-spiro [6-fluoro] PHARMACEUTICAL DOSAGE FORM 4, B] INDOL] -4-AMINE
RU2009116087A (en) METHOD FOR MEDICINAL REDUCTION OF OXIDATIVE STRESS LEVEL IN PATIENTS WITH ARTERIAL HYPERTENSION
TH0701000864A (en) Pharmaceutical combinations for the treatment and/or chemosensitization of tumors resistant to anticancer drugs.